Anteris Technologies Global Corp. AVR
At closeNov 10, 2026, 4:00 PM EST
After hours · Nov 10, 4:00 PM ET
- YTD
- +18.04%
- 1 year
- +49.11%
- Market cap
- 573.35M
- Revenue (ttm)
- 1.85M
- EPS (ttm)
- -1.95
- Shares out
- 97.34M
- Forward P/E
- -10.79
- YTD return
- +18.04%
- 1-year return
- +49.11%
- Volume
- 778.73K
- Avg volume
- 1.12M
- Open
- 5.85
- Previous close
- 5.94
- Day's range
- 5.77 – 6.02
- 52-week range
- 3.30 – 11.06
- Beta
- 0.73
- Analysts
- Strong Buy
- Price target
- 15.33 (+160.3%)
- Earnings date
- Aug 14, 2026
5D -0.02 (-0.34%)
Key statistics
- Enterprise value
- 717.79M
- PEG ratio
- 0.00
- Price / sales
- 555.87
- Price / book
- 3.69
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- -11.20%
- Free cash flow
- -52.66M
- Total cash
- 282.70M
- Total debt
- 3.73M
- Return on equity
- -59.21%
- Short % of float
- 8.34%
- 50-day average
- 8.23
- 200-day average
- 5.95
Analyst view
Consensus: strong buy
- Target (low)
- 15.00
- Target (mean)
- 15.33
- Target (high)
- 16.00
- Strong buy0
- Buy3
- Hold0
- Sell0
- Strong sell0
Next earnings
Aug 14, 2026
Expected Aug 14, 2026. Consensus EPS estimate -0.20667.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 14, 2026 | Jun 30, 2026 | -0.2073 | — | — | — |
| May 12, 2026 | Mar 31, 2026 | -0.2073 | -0.28 | -0.07 | -35.07% |
| Mar 11, 2026 | Dec 31, 2025 | -0.27083 | -0.74 | -0.47 | -173.23% |
| Nov 10, 2025 | Sep 30, 2025 | -0.54233 | -0.62 | -0.08 | -14.32% |
| Aug 12, 2025 | Jun 30, 2025 | -0.545 | -0.58 | -0.03 | -6.42% |
| May 13, 2025 | Mar 31, 2025 | -0.53333 | -0.61 | -0.08 | -14.38% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 15, 2026 | Barclays | main | Overweight | Overweight |
| Mar 27, 2026 | Cantor Fitzgerald | reit | Overweight | Overweight |
| Mar 11, 2026 | Wells Fargo | init | — | Overweight |
| Jan 8, 2025 | Lake Street | init | — | Buy |
| Jan 7, 2025 | TD Cowen | init | — | Buy |
| Jan 7, 2025 | Cantor Fitzgerald | init | — | Overweight |
About Anteris Technologies Global Corp.
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- Australia
- Website
- anteristech.com
News
Anteris Technologies Announces Results for the Third Quarter of 2026 
Anteris Technologies To Present First 30-Day Clinical And Hemodynamic Outcomes For Its Medium-Size DurAVR Transcatheter Heart Valve At The Transcatheter Cardiovascular Therapeutics Conference, October 31-November 3 
Cantor Fitzgerald Reiterates Overweight on Anteris Technologies Glb, Maintains $15 Price Target 
Why Enovix Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Your note
Sign in to keep a note on AVR — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DENARO STEPHEN | Director | Conversion of Exercise of derivative security | Mar 10, 2025 | 0 |
| KNIGHT SUSAN ELIZABETH | Director | Purchase | Jun 1, 2026 | 11,000 |
| L1 CAPITAL PTY. LTD. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Jan 21, 2026 | 0 |
| MCDONNELL MATTHEW | Chief Financial Officer | Conversion of Exercise of derivative security | Jun 4, 2026 | 0 |
| MOSS GREGORY S. ESQ. | Director | Conversion of Exercise of derivative security | Jun 4, 2026 | 17,580 |
| PATERSON WAYNE | Chief Executive Officer | Conversion of Exercise of derivative security | Dec 15, 2025 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| L1 Capital Pty Ltd | 8.00% | 7,789,000 | 82.33M | Mar 30, 2026 |
| Nantahala Capital Management, LLC | 5.68% | 5,530,910 | 58.46M | Mar 30, 2026 |
| Sio Capital Management, LLC | 5.53% | 5,382,965 | 56.90M | Mar 30, 2026 |
| Blackrock Inc. | 5.02% | 4,889,153 | 51.68M | Mar 30, 2026 |
| Adar1 Capital Management, LLC | 3.89% | 3,789,132 | 40.05M | Mar 30, 2026 |
| Perceptive Advisors Llc | 3.52% | 3,425,476 | 36.21M | Mar 30, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Russell 2000 ETF | 1.90% | 1,849,589 | 19.55M | Apr 29, 2026 |
| Fidelity Investment Trust-Fidelity Pacific Basin Fund | 1.84% | 1,795,137 | 18.97M | May 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 0.88% | 857,279 | 9.06M | Mar 30, 2026 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 0.81% | 785,732 | 8.31M | Apr 29, 2026 |
| iShares Trust-iShares Russell 2000 Growth ETF | 0.66% | 643,786 | 6.80M | Apr 29, 2026 |
| Fidelity Investment TRT-Fidelity Intl Small Cap Opportunities Fd. | 0.46% | 449,000 | 4.75M | Apr 29, 2026 |